Global Acute Heart Failure (AHF) Therapeutics Strategic Business Opportunity Outlook 2018-2022 – Novel Treatments Offer a Ray of Hope – ResearchAndMarkets.com

The “Acute
Heart Failure (AHF) Therapeutics – Global Strategic Business Report”
report has been added to ResearchAndMarkets.com’s
offering.

The report provides separate comprehensive analytics for the US, Canada,
Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual
estimates and forecasts are provided for the period 2015 through 2022.
Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Next Generation
Sequencers in US$ Thousand.

The Global market is additionally analyzed by the following
End-Use Segments:

The report profiles 93 companies including many key and niche
players such as:

Key Topics Covered

1. Industry Overview

2. Market Drivers, Trends & Issues

3. Treatment of Acute Heart Failure (AHF)

4. Acute Heart Failure

5. Recent Industry Activity

6. Focus on Select Players

7. Global Market Perspective

Total Companies Profiled: 34 (including Divisions/Subsidiaries
35)

For more information about this report visit https://www.researchandmarkets.com/research/j95wwt/global_acute?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005741/en/

Leave a Comment